18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment

18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment

BackgroundThe aim of this study was to evaluate 18F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography (18F-RGD PET/CT) and serum inflammation biomarkers for predicting outcomes of patients receiving combined antiangiogenic treatment for advanced non-small cell lung cancer (NSCLC).Metho...

Full description

Bibliographic Details
Main Authors: Jie Liu, Leilei Wu, Zhiguo Liu, Samuel Seery, Jianing Li, Zhenhua Gao, Jinming Yu, Xue Meng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
18F-RGD PET/CT
inflammatory biomarkers
outcome prediction
combined antiangiogenic therapy
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.671912/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.671912/full

Similar Items